Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

shutterstock_79370437

Hanmi terminates lung cancer drug after being muscled out by AZ’s Tagrisso

April 13, 2018 Medical Communications, Research and Development AstraZeneca, Cancer, Otila, Tagrisso, hanmi, lung cancer, pharma

South Korea’s Hanmi Pharmaceutical has announced its intention to terminate development of its lung cancer drug Olita (olmutinib) as it …
News
180405-evolution-of-kidney-cancer

Evolutionary path of kidney cancer tracked, “born to be bad” type discovered

April 13, 2018 Medical Communications, Research and Development Kidney cancer, biotech, drugs, pharma, pharmaceutical

A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …
News
eisa0003

Eisai forms partnership to find new tuberculosis treatment

April 13, 2018 Medical Communications, Research and Development Colorado State University, Eisai, broad institute, pharma, tuberculosis, university of chicago

Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of …
News
roche__tree

Roche’s immunotherapy lucky streak ends with deaths in trial

April 13, 2018 Medical Communications, Research and Development Exelixis, Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Roche’s Tecentriq had begun to show signs of reviving its hopes in the competitive PD-1/L1 market, succeeding in two Phase …
News

Wickham Labs Announces Upcoming Webinar on Regulatory Changes in Medical Device Development

April 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wickham laboratories

Come join Wickham Laboratories and Patient Guard for this free webinar on May 23rd to discuss Regulatory Changes in Medical …
News
Press release
photo_ivana_magovcevic-liebisch3

Ipsen bolsters executive leadership with two new recruits

April 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …
Appointment
hcv_credit_bruceblaus

New hepatitis C combo boasts 97% cure rate for just $300

April 12, 2018 Research and Development AbbVie, DNDi, Drugs for Neglected Diseases initiative, Gilead, HCV, Pharco Pharmaceuticals, hepatitis C, pharma, sovaldi

A partnership of the not-for-profit organisation Drugs for Neglected Diseases initiative (DNDi) and Egyptian drug firm Pharco Pharmaceuticals is working …
News
kris-sterkens-23052017-hr-1

Working Life: Kris Sterkens, Company Group Chairman, Janssen EMEA

April 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Janssen, Johnson & Johnson, Kris Sterkens, pharma

Pharmafile.com sat down with Kris Sterkens, Company Group Chairman of Janssen’s EMEA operations to discuss nearly three decades at the …
Feature
hands-981400_960_720

Alzheimer’s protein treatment that works in human cells

April 12, 2018 Research and Development Alzheimer's disease, Gladstone Institutes, biotech, drugs, pharma, pharmaceutical

One of the major stumbling blocks that science has come up against, when trying to develop potential treatments for Alzheimer’s …
News
kenneth-newman_credit_verona_pharma

Verona Pharma loses Chief Medical Officer

April 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, verona pharma

Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …
Appointment
abbvieuse_054_low

AbbVie’s rheumatoid arthritis drug bests even its own blockbuster Humira at Phase 3

April 11, 2018 Research and Development AbbVie, Humira, pharma, rheumatoid arthritis, upadacitinib

AbbVie posted a strong showing this week from its JAK1 inhibitor upadacitinib, indicating that the drug outperformed even its own …
News
csm_packshot_kineret_814229b3fc

Sobi receives expanded EU approval for Kineret

April 11, 2018 Research and Development, Sales and Marketing Kineret, anti-inflammatory, biotech, drugs, pharma, pharmaceutical, sobi

Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given approval …
News
pfizer_hq_dark

Pfizer shuts down kidney cancer drug trial due to “futility”

April 11, 2018 Research and Development Cancer, Kidney cancer, Pfizer, inlyta, pharma

Pfizer has revealed that it has shut down a trial of its vascular endothelial growth factor (VEGF) inhibitor Inlyta (axitinib) …
News

Alexion $855m portfolio boost after Wilson Therapeutics buyout

April 11, 2018 Research and Development, Sales and Marketing Alexion, Wilson's Therapeutics, Wilson's disease, biotech, drugs, pharma, pharmaceutical

Alexion Pharmaceuticals is badly in need of alternative revenue streams to Soliris, its mega-blockbuster that could start to face competition …
News
mylan

Mylan looks to hit Teva where it hurts, eyeing slow-release MS treatment

April 11, 2018 Research and Development, Sales and Marketing Copaxone, Mapi Pharma, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan has taken several steps recently that seem intended to hit sales of its big rivals on their key products, …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026